| P/E (FY) | — | Sales (TTM) | $86.3M |
| Earnings (TTM) | $78.2M | ROE | −16.72% |
| Net Margin | −87.77% | ROIC | −28.62% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | −4.49% |
Standard BioTools develops, manufactures, and sells instrumentation, consumables, and services for scientists and biomedical researchers across the Americas, EMEA, and Asia-Pacific through its Proteomics and Genomics segments. Its offerings include instruments, consumables, and assays for clinical and diagnostic uses, the SomaScan platform for measuring proteins, the CyTOF mass cytometry platform using metal-tagged antibodies, and the Hyperion spatial biology platform for tissue analysis.
| Market Cap | $310.0M | Trading Days | 1138 |
| 52W High | 1.72 |
| 52W Low | 0.70 |
| % Off High | −53.80% |
| YTD | −37.91% | 1Y | −44.04% |
| 3Y | −66.89% | 5Y | −60.07% |
| 10Y | −60.07% | Since incept. (ann.) | −9.89% |
EMEA 42% · Americas 36% · Asia Pacific 22%
| Ann. Volatility (1Y) | 68.11% | Ann. Volatility (3Y) | 76.42% |
| Sharpe (1Y) | −0.52 | Sharpe (3Y) | −0.08 |
| Max Drawdown (1Y) | −56.55% | Max Drawdown (3Y) | −76.07% |
| Beta (3Y, vs SPY) | 1.32 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| HBIO | HARVARD BIOSCIENCE INC | $262.8M | — |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $431.7M | — |
| CTKB | Cytek Biosciences, Inc. | $576.0M | — |
| QTRX | Quanterix Corp | $164.4M | — |
| NAUT | Nautilus Biotechnology, Inc. | $152.5M | — |
| ASTC | ASTROTECH Corp | $124.9M | — |
| SEER | Seer, Inc. | $117.7M | — |
| EYPT | EyePoint, Inc. | $1.00B | — |
| RPID | RAPID MICRO BIOSYSTEMS, INC. | $92.0M | — |
| ALMR | Alamar Biosciences, Inc. | $1.69B | — |
| PRPO | Precipio, Inc. | $40.5M |
| — |
| TXG | 10x Genomics, Inc. | $5.87B | — |
